About us
Pipeline
AT-001
AT-004
Our Science
Team
The Pulse
Partner with us
The Pulse
News
Insights
Events
Infographics
←
→
The Pulse
News
Insights
Events
Infographics
Arctic Therapeutics Receives EMA Approval for Phase IIa Study of AT-001 in Alzheimer’s Disease
Latest
Arctic Therapeutics Announces Enrollment of First Patients in Phase IIa Trial of AT-004 for Acne Vulgaris
Why Safety Must Come First in Acne Treatment: Lessons from Recent Product Recalls
By
Serena Taylor
Acne’s toll on self-esteem
By
Serena Taylor
The Global Burden of Atopic Dermatitis: What the Numbers Reveal
By
Serena Taylor
CLEC16A: The gene at the crossroads of immunity and neurodegeneration
By
Serena Taylor
Show more